FOXO4-DRI

Pulsed FOXO4–p53 disruptor (Baar 2017). Not a daily repair peptide.

What it does / how it works

A designed peptide that pries FOXO4 off p53 in senescent cells so those cells can die. Used as a short pulse, not a daily repair drug.

Class Senolytic research peptide
Typical vial 10 mg
Reconstitution 1–2 mL BAC per 10 mg
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Pulse week 5-8 mg 3 doses across 1 week (e.g. 1 week SubQ
Goal Dose How often How long Route
    Mon / Wed / Fri)    
Weeks 2-8 None Off 3-8 weeks off –
Repeat optional Same 3-dose week Then off again Do not run daily SubQ

Watch: Pulse, then off. Do not run daily for months.

FOXO4-DRI FAQ — Australia

FOXO4-DRI was designed to disrupt the FOXO4–p53 interaction in senescent cells (Baar et al., Cell 2017). It is a pulsed senolytic concept, not a daily repair peptide.

Recommended Supplier — FOXO4-DRI Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
AUD Australian dollar